- Lattice Biologics (OTCPK:LBLTF): Q2 EPS of $0.00
- More news on: Lattice Biologics Ltd, Earnings news and commentary, Healthcare stocks news, , Read more ...
home / stock / lbltf / lbltf news
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Lattice Biologics Ltd Company Name:
LBLTF Stock Symbol:
Market:
Late in the trading day on Friday, July, 9, Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) issued an update on the company which has been unable to trade its stock for over a month. The company had originally made biologic products for use in the field of bone regeneration i...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for Q2 2021. Highlights of Six Months Ended March 31, 2021 Sales and Product Offerings ...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“Lattice” or the “Company”), an emerging leader in psilocybin research and cannabis company, today announced the formation of its Strategic Advisory Board, a group of respected business leaders that wi...